Research Article
Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer
Table 1
Characteristics of NSCLC patients for differentially expressed serum exosomal miR-620.
| Characteristics | No. of cases | Median | value |
| Age (y) | <62 | 115 | 5.4500 | 0.235 | ≥62 | 120 | 5.2350 | Gender | Male | 141 | 5.3550 | 0.361 | Female | 94 | 5.1625 | Smoking | Yes | 122 | 5.3150 | 0.502 | No | 113 | 5.2800 | Drinking | Yes | 76 | 5.1075 | 0.008 | No | 159 | 5.4100 | Pathology diagnosis | AC | 165 | 5.3906 | 0.988 | SCC | 59 | 5.2500 | Other | 11 | 5.3823 | Lymph node metastasis | Yes | 106 | 5.4250 | 0.233 | No | 129 | 5.2000 | TNM staging | I-II | 129 | 5.2450 | 0.440 | III-IV | 105 | 5.4100 | Distant metastasis | Yes | 62 | 5.6626 | 0.037 | No | 173 | 5.2000 |
|
|
AC, adenocarcinoma; SCC, squamous cell carcinoma.
|